In recent years, India’s pharmaceutical landscape has witnessed a significant transformation. Beyond being the “pharmacy of the world” for affordable medicines, India is emerging as a preferred global...
Key Highlights: Implications: India’s GATINN catapults Servier into SPC dominance, crushing fragmented chronic therapy rivals while exploding patient compliance across emerging marke...
